JP2006117704A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006117704A5 JP2006117704A5 JP2006025034A JP2006025034A JP2006117704A5 JP 2006117704 A5 JP2006117704 A5 JP 2006117704A5 JP 2006025034 A JP2006025034 A JP 2006025034A JP 2006025034 A JP2006025034 A JP 2006025034A JP 2006117704 A5 JP2006117704 A5 JP 2006117704A5
- Authority
- JP
- Japan
- Prior art keywords
- pge1
- freeze
- maltose
- weight
- product according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000000047 product Substances 0.000 claims 27
- GMVPRGQOIOIIMI-UHFFFAOYSA-N (8R,11R,12R,13E,15S)-11,15-Dihydroxy-9-oxo-13-prostenoic acid Natural products CCCCCC(O)C=CC1C(O)CC(=O)C1CCCCCCC(O)=O GMVPRGQOIOIIMI-UHFFFAOYSA-N 0.000 claims 23
- 229960000711 alprostadil Drugs 0.000 claims 23
- GMVPRGQOIOIIMI-DWKJAMRDSA-N prostaglandin E1 Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(O)=O GMVPRGQOIOIIMI-DWKJAMRDSA-N 0.000 claims 23
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims 13
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims 13
- 229920000858 Cyclodextrin Polymers 0.000 claims 10
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 claims 10
- 238000000354 decomposition reaction Methods 0.000 claims 9
- 238000003860 storage Methods 0.000 claims 8
- 238000004519 manufacturing process Methods 0.000 claims 7
- 150000001875 compounds Chemical class 0.000 claims 5
- 239000007857 degradation product Substances 0.000 claims 5
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims 3
- 238000009472 formulation Methods 0.000 claims 3
- 239000000203 mixture Substances 0.000 claims 3
- 239000007864 aqueous solution Substances 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 238000004811 liquid chromatography Methods 0.000 claims 2
- 229920001450 Alpha-Cyclodextrin Polymers 0.000 claims 1
- 208000031104 Arterial Occlusive disease Diseases 0.000 claims 1
- 208000002330 Congenital Heart Defects Diseases 0.000 claims 1
- 208000031481 Pathologic Constriction Diseases 0.000 claims 1
- HFHDHCJBZVLPGP-RWMJIURBSA-N alpha-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO HFHDHCJBZVLPGP-RWMJIURBSA-N 0.000 claims 1
- 229940043377 alpha-cyclodextrin Drugs 0.000 claims 1
- 208000021328 arterial occlusion Diseases 0.000 claims 1
- 230000017531 blood circulation Effects 0.000 claims 1
- 230000001684 chronic effect Effects 0.000 claims 1
- 208000028831 congenital heart disease Diseases 0.000 claims 1
- 230000001419 dependent effect Effects 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 208000035475 disorder Diseases 0.000 claims 1
- 239000002552 dosage form Substances 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 230000008014 freezing Effects 0.000 claims 1
- 238000007710 freezing Methods 0.000 claims 1
- 210000005259 peripheral blood Anatomy 0.000 claims 1
- 239000011886 peripheral blood Substances 0.000 claims 1
- 238000002360 preparation method Methods 0.000 claims 1
- 230000000069 prophylactic effect Effects 0.000 claims 1
- 239000000243 solution Substances 0.000 claims 1
- 208000037804 stenosis Diseases 0.000 claims 1
- 230000036262 stenosis Effects 0.000 claims 1
- 229940124597 therapeutic agent Drugs 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
- NZYDCCAWWIOPFI-SGOYRCKQSA-N CCCCC/C=C/C=C/[C@H]([C@@H](CCCCCCC(O)=O)C(C1)=O)[C@@H]1O Chemical compound CCCCC/C=C/C=C/[C@H]([C@@H](CCCCCCC(O)=O)C(C1)=O)[C@@H]1O NZYDCCAWWIOPFI-SGOYRCKQSA-N 0.000 description 1
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006025034A JP2006117704A (ja) | 2003-11-13 | 2006-02-01 | プロスタグランジン含有凍結乾燥品 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003384252 | 2003-11-13 | ||
JP2006025034A JP2006117704A (ja) | 2003-11-13 | 2006-02-01 | プロスタグランジン含有凍結乾燥品 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2005515457A Division JP3829874B2 (ja) | 2003-11-13 | 2004-11-12 | プロスタグランジン含有凍結乾燥品 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2006117704A JP2006117704A (ja) | 2006-05-11 |
JP2006117704A5 true JP2006117704A5 (ru) | 2007-11-29 |
Family
ID=36535896
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2006025034A Withdrawn JP2006117704A (ja) | 2003-11-13 | 2006-02-01 | プロスタグランジン含有凍結乾燥品 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2006117704A (ru) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109394704B (zh) * | 2018-11-27 | 2021-09-17 | 西安力邦肇新生物科技有限公司 | 一种前列腺素e1甲酯注射用冻干制剂及制备和应用 |
-
2006
- 2006-02-01 JP JP2006025034A patent/JP2006117704A/ja not_active Withdrawn
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2013511557A5 (ru) | ||
US20200347153A1 (en) | Methods for forming inclusion complexes with hydrophilic beta-cyclodextrin derivatives and compositions thereof | |
JP6282644B2 (ja) | ラセカドトリル液体組成物 | |
FI3258919T4 (fi) | Nasaalinen jauheformulaatio hypoglykemian hoitoon | |
CZ20031878A3 (cs) | Směsi modafinilové sloučeniny a cyklodextrinu | |
EP2720723A1 (en) | Stabilized voriconazole composition | |
EA009714B1 (ru) | Препараты кладрибина для улучшенной пероральной доставки и доставки через слизистые оболочки | |
TWI343262B (en) | Rapidly disintegrating lyophilized oral formulations of a thrombin receptor antagonist | |
WO2001041757A1 (fr) | Composition pharmaceutique contenant de la cyclodextrine | |
JP2005314413A (ja) | 経口投与用医薬組成物 | |
JP2019131596A5 (ru) | ||
JP2017500357A (ja) | ラセカドトリル液体組成物 | |
KR101504862B1 (ko) | 리마프로스트와 β-시클로덱스트린을 함유하는 정제 | |
JP6549428B2 (ja) | 経口組成物 | |
JP2006117704A5 (ru) | ||
JPH10167958A (ja) | ロキソプロフェンナトリウム類を含有する口腔内速溶性製剤及びその製造方法 | |
CN102772383A (zh) | 阿奇霉素组合物冻干口腔崩解片及其制备方法 | |
JP6084371B2 (ja) | 薬剤安定化医薬組成物 | |
CN106667944A (zh) | 含有前列腺素类药物的缓释制剂 | |
JP2000038342A (ja) | 褥瘡・損傷皮膚修復用製剤 | |
JP3829874B2 (ja) | プロスタグランジン含有凍結乾燥品 | |
JPWO2012014746A1 (ja) | αリポ酸複合体 | |
JP5692674B1 (ja) | カルシウム低吸収型経口リン吸着剤 | |
JP6239282B2 (ja) | 腎不全改善剤 | |
JP6382667B2 (ja) | L−アスコルビン酸徐放性製剤 |